What happens when someone examines your sore joint?

How will they find the sore part?

The exam checks your strength, swelling and tender spots. You'll be asked which motions hurt and whether the ache travels. An older X-ray may show wear or an old injury. More tests may come first when the cause isn't clear.

The medicine can wait until the person examining you knows what hurts.

What is an ultrasound guided knee injection like?

Ultrasound shows the needle on a screen as it moves. That can help when the joint is deep or the target is small. You'll feel the skin cleaning and the needle going in. The screen helps with placement, but it can't promise relief.

It shows where the needle went, not how your knee will respond.

What will the rest of the day be like?

The area may feel sore after the visit. You'll get simple directions about bathing, movement and your regular medicine. Keep the office number close if swelling keeps rising. Fever, heat or soreness that grows fast calls for medical help.

A quiet day is usually easier to plan than a busy one.

What if the ache keeps coming back?

At its Chandler office, QC Kinetix offers a consultation and exam. Its regenerative treatments are non-surgical care made after staff collect some of your blood or bone marrow. They're offered to ease soreness without surgery. Medical providers are the licensed staff who give that care.

They'll explain the visit before you decide whether it fits.

Sources

1. A clinical review of peripheral joint injections frames them as a treatment for joint-mediated pain (arthritis, tendinopathy, bursitis) that has NOT responded to conservative management, and states plainly that these injections are typically not curative - their objective is to reduce pain enough to allow physical and pharmacologic rehabilitation to work.

   Marcolina A, et al. — Peripheral Joint Injections.. Phys Med Rehabil Clin N Am, 2022. DOI: 10.1016/j.pmr.2022.01.005.

2. A systematic review of ultrasound versus anatomic (landmark) guidance found needle-placement accuracy was greater with ultrasound guidance at every anatomic site, and short-term (<6 weeks) symptom onset improved, but long-term outcomes were NOT shown to differ between the two techniques; the accuracy advantage was largest in small joints.

   Gilliland CA, et al. — Ultrasound versus anatomic guidance for intra-articular and periarticular injection: a systematic review.. Phys Sportsmed, 2011. DOI: 10.3810/psm.2011.09.1928.

3. A systematic review of corticosteroid effects on articular cartilage found a time- and dose-dependent pattern: at low doses (roughly under 2-3 mg per dose in vivo) methylprednisolone, hydrocortisone and triamcinolone were associated with cell growth and recovery, while at higher doses (over 3 mg per dose, or 18-24 mg cumulative) they caused significant gross cartilage damage and chondrocyte toxicity.

   Wernecke C, et al. — The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review.. Orthop J Sports Med, 2015. DOI: 10.1177/2325967115581163.

4. A review of systemic absorption after locally injected glucocorticoid found substantial individual variability, and established that both intra-articular and epidural injections can produce systemic effects lasting WEEKS - while noting there are no guidelines addressing systemic absorption or overall systemic risk.

   Stout A, et al. — Systemic Absorption and Side Effects of Locally Injected Glucocorticoids.. PM R, 2019. DOI: 10.1002/pmrj.12042.

5. A 2017 MMWR outbreak report describes 41 cases of septic arthritis following intra-articular injections given during 250 patient visits at a single New Jersey outpatient practice, 30 (73%) of whom needed surgery; recovered organisms were oral flora and the investigation found multiple breaches of infection-prevention practice.

   Ross K, et al. — Outbreak of Septic Arthritis Associated with Intra-Articular Injections at an Outpatient Practice - New Jersey, 2017.. MMWR Morb Mortal Wkly Rep, 2017. DOI: 10.15585/mmwr.mm6629a3.

6. A systematic review of 105 clinical orthopaedic PRP studies found only 11 (10%) described the preparation protocol well enough to be repeated, and only 17 (16%) reported quantitative metrics on the composition of the final PRP product - so 'PRP' in one trial is frequently not the same product as 'PRP' in another.

   Chahla J, et al. — A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature.. J Bone Joint Surg Am, 2017. DOI: 10.2106/JBJS.16.01374.